{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:41:05Z","timestamp":1793108465840,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["ED481B-2023-092"],"award-info":[{"award-number":["ED481B-2023-092"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["ED481B-2023-063"],"award-info":[{"award-number":["ED481B-2023-063"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["IN606B-2023\/006"],"award-info":[{"award-number":["IN606B-2023\/006"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["ED431C 2025\/08"],"award-info":[{"award-number":["ED431C 2025\/08"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministry of Science and Innovation of Spain","doi-asserted-by":"crossref","award":["PID2022-142350OB-C21"],"award-info":[{"award-number":["PID2022-142350OB-C21"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02189-4","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:28:09Z","timestamp":1785342489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of high cyclodextrins concentrations on ocular safety and surface permanence"],"prefix":"10.1007","author":[{"given":"Victoria","family":"D\u00edaz-Tom\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurxo","family":"Garc\u00eda-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bendicho-Lavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Dom\u00ednguez-Arca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Cuello-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxo","family":"Fern\u00e1ndez-Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-2253","authenticated-orcid":false,"given":"Francisco J.","family":"Otero-Espinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2189_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","volume":"59","author":"ME Brewster","year":"2007","unstructured":"Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 2007;59:645\u201366. https:\/\/doi.org\/10.1016\/j.addr.2007.05.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"2189_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/17425247.2.1.335","volume":"2","author":"T Loftsson","year":"2005","unstructured":"Loftsson T, Jarho P, M\u00e1sson M, J\u00e4rvinen T. Cyclodextrins in drug delivery. Expert Opin Drug Deliv. 2005;2:335\u201351. https:\/\/doi.org\/10.1517\/17425247.2.1.335.","journal-title":"Expert Opin Drug Deliv"},{"key":"2189_CR3","unstructured":"European Medicines Agency (EMA). Background review for cyclodextrins used as excipients. 2014;17."},{"key":"2189_CR4","doi-asserted-by":"publisher","first-page":"101153","DOI":"10.1016\/j.jddst.2019.101153","volume":"53","author":"ACSGV Santana","year":"2019","unstructured":"Santana ACSGV, Nadvorny D, da Rocha Passos TD, de La Roca Soares MF, Soares-Sobrinho JL. Influence of cyclodextrin on posaconazole stability, release and activity: Improve the utility of the drug. J Drug Deliv Sci Technol. 2019;53:101153. https:\/\/doi.org\/10.1016\/j.jddst.2019.101153.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2189_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1021\/js950534b","volume":"85","author":"T Loftsson","year":"1996","unstructured":"Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996;85:1017\u201325. https:\/\/doi.org\/10.1021\/js950534b.","journal-title":"J Pharm Sci"},{"key":"2189_CR6","doi-asserted-by":"publisher","first-page":"5260976","DOI":"10.1155\/2018\/5260976","volume":"2018","author":"H Abdelkader","year":"2018","unstructured":"Abdelkader H, Fathalla Z, Moharram H, Ali TFS, Pierscionek B. Cyclodextrin Enhances Corneal Tolerability and Reduces Ocular Toxicity Caused by Diclofenac. Oxid Med Cell Longev. 2018;2018:5260976. https:\/\/doi.org\/10.1155\/2018\/5260976.","journal-title":"Oxid Med Cell Longev"},{"key":"2189_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.04.010","volume":"531","author":"T Loftsson","year":"2017","unstructured":"Loftsson T, Stef\u00e1nsson E. Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye. Int J Pharm. 2017;531:413\u201323. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.04.010.","journal-title":"Int J Pharm"},{"key":"2189_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/pharmaceutics13020149","volume":"13","author":"X Garc\u00eda-Otero","year":"2021","unstructured":"Garc\u00eda-Otero X, D\u00edaz-Tom\u00e9 V, Varela-Fern\u00e1ndez R, Mart\u00edn-Pastor M, Gonz\u00e1lez-Barcia M, Blanco-M\u00e9ndez J, et al. Development and Characterization of a Tacrolimus\/Hydroxypropyl-\u03b2-Cyclodextrin Eye Drop. Pharmaceutics. 2021;13:149. https:\/\/doi.org\/10.3390\/pharmaceutics13020149.","journal-title":"Pharmaceutics"},{"key":"2189_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijpharm.2015.07.040","volume":"493","author":"S J\u00f3hannsd\u00f3ttir","year":"2015","unstructured":"J\u00f3hannsd\u00f3ttir S, Jansook P, Stef\u00e1nsson E, Loftsson T. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations. Int J Pharm. 2015;493:86\u201395. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.07.040.","journal-title":"Int J Pharm"},{"key":"2189_CR10","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1021\/acsami.0c18926","volume":"13","author":"R Varela-Fern\u00e1ndez","year":"2021","unstructured":"Varela-Fern\u00e1ndez R, Garc\u00eda-Otero X, D\u00edaz-Tom\u00e9 V, Regueiro U, L\u00f3pez-L\u00f3pez M, Gonz\u00e1lez-Barcia M, et al. Design, Optimization, and Characterization of Lactoferrin-Loaded Chitosan\/TPP and Chitosan\/Sulfobutylether-\u03b2-cyclodextrin Nanoparticles as a Pharmacological Alternative for Keratoconus Treatment. ACS Appl Mater Interfaces. 2021;13:3559\u201375. https:\/\/doi.org\/10.1021\/acsami.0c18926.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2189_CR11","doi-asserted-by":"publisher","first-page":"121654","DOI":"10.1016\/j.ijpharm.2022.121654","volume":"618","author":"P Jansook","year":"2022","unstructured":"Jansook P, Loftsson T. Self-assembled \u03b3-cyclodextrin as nanocarriers for enhanced ocular drug bioavailability. Int J Pharm. 2022;618:121654. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121654.","journal-title":"Int J Pharm"},{"key":"2189_CR12","doi-asserted-by":"publisher","first-page":"120318","DOI":"10.1016\/j.ijpharm.2021.120318","volume":"597","author":"V D\u00edaz-Tom\u00e9","year":"2021","unstructured":"D\u00edaz-Tom\u00e9 V, Garc\u00eda-Otero X, Varela-Fern\u00e1ndez R, Mart\u00edn-Pastor M, Conde-Penedo A, Aguiar P, et al. In situ forming and mucoadhesive ophthalmic voriconazole\/HP\u03b2CD hydrogels for the treatment of fungal keratitis. Int J Pharm. 2021;597:120318. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120318.","journal-title":"Int J Pharm"},{"key":"2189_CR13","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.3390\/polym14153170","volume":"14","author":"B Grassiri","year":"2022","unstructured":"Grassiri B, Cesari A, Balzano F, Migone C, Kali G, Bernkop-Schn\u00fcrch A, et al. Thiolated 2-Methyl-\u03b2-Cyclodextrin as a Mucoadhesive Excipient for Poorly Soluble Drugs: Synthesis and Characterization. Polymers. 2022;14:3170. https:\/\/doi.org\/10.3390\/polym14153170.","journal-title":"Polymers"},{"key":"2189_CR14","doi-asserted-by":"publisher","unstructured":"Budai-Sz\u0171cs M, Kiss EL, Szil\u00e1gyi B\u00c1, Szil\u00e1gyi A, Gyarmati B, Berk\u00f3 S et al. Mucoadhesive Cyclodextrin-Modified Thiolated Poly(aspartic acid) as a Potential Ophthalmic Drug Delivery System. Polymers. Multidisciplinary Digital Publishing Institute; 2018;10:199. https:\/\/doi.org\/10.3390\/polym10020199","DOI":"10.3390\/polym10020199"},{"key":"2189_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/scipharm87030015","volume":"87","author":"T B\u00edr\u00f3","year":"2019","unstructured":"B\u00edr\u00f3 T, Aigner Z. Current Approaches to Use Cyclodextrins and Mucoadhesive Polymers in Ocular Drug Delivery\u2014A Mini-Review. Sci Pharm Multidisciplinary Digit Publishing Inst. 2019;87:15. https:\/\/doi.org\/10.3390\/scipharm87030015.","journal-title":"Sci Pharm Multidisciplinary Digit Publishing Inst"},{"key":"2189_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/pharmaceutics15010035","volume":"15","author":"V D\u00edaz-Tom\u00e9","year":"2023","unstructured":"D\u00edaz-Tom\u00e9 V, Bendicho-Lavilla C, Garc\u00eda-Otero X, Varela-Fern\u00e1ndez R, Mart\u00edn-Pastor M, Llovo-Taboada J, et al. Antifungal Combination Eye Drops for Fungal Keratitis Treatment. Pharm Multidisciplinary Digit Publishing Inst. 2023;15:35. https:\/\/doi.org\/10.3390\/pharmaceutics15010035.","journal-title":"Pharm Multidisciplinary Digit Publishing Inst"},{"key":"2189_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijpharm.2017.07.044","volume":"529","author":"S J\u00f3hannsd\u00f3ttir","year":"2017","unstructured":"J\u00f3hannsd\u00f3ttir S, Kristinsson JK, F\u00fcl\u00f6p Z, \u00c1sgr\u00edmsd\u00f3ttir G, Stef\u00e1nsson E, Loftsson T. Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles. Int J Pharm. 2017;529:486\u201390. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.07.044.","journal-title":"Int J Pharm"},{"key":"2189_CR18","doi-asserted-by":"publisher","unstructured":"Jansook P, Soe HMSH, Asasutjarit R, Tun T, Hnin HM, Maw PD, et al. Celecoxib\/Cyclodextrin Eye Drop Microsuspensions: Evaluation of. Vitro Cytotoxicity and Anti-VEGF Efficacy for Retinal Diseases. Pharmaceutics [Internet]. Multidisciplinary Digital Publishing Institute; 2023. [cited 2026 June 21];15. https:\/\/doi.org\/10.3390\/pharmaceutics15122689.","DOI":"10.3390\/pharmaceutics15122689"},{"key":"2189_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/nano10040709","volume":"10","author":"B Lorenzo-Veiga","year":"2020","unstructured":"Lorenzo-Veiga B, Diaz-Rodriguez P, Alvarez-Lorenzo C, Loftsson T, Sigurdsson HH. Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation. Nanomaterials Basel Switz. 2020;10:709. https:\/\/doi.org\/10.3390\/nano10040709.","journal-title":"Nanomaterials Basel Switz"},{"key":"2189_CR20","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/molecules26051492","volume":"26","author":"M Prajapati","year":"2021","unstructured":"Prajapati M, Christensen G, Paquet-Durand F, Loftsson T. Cytotoxicity of \u03b2-Cyclodextrins in Retinal Explants for Intravitreal Drug Formulations. Molecules Basel Switz. 2021;26:1492. https:\/\/doi.org\/10.3390\/molecules26051492.","journal-title":"Molecules Basel Switz"},{"key":"2189_CR21","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.xphs.2017.12.028","volume":"107","author":"V D\u00edaz-Tom\u00e9","year":"2018","unstructured":"D\u00edaz-Tom\u00e9 V, Luaces-Rodr\u00edguez A, Silva-Rodr\u00edguez J, Blanco-Dorado S, Garc\u00eda-Quintanilla L, Llovo-Taboada J, et al. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis. J Pharm Sci. 2018;107:1342\u201351. https:\/\/doi.org\/10.1016\/j.xphs.2017.12.028.","journal-title":"J Pharm Sci"},{"key":"2189_CR22","doi-asserted-by":"publisher","unstructured":"Puente-Iglesias M, Cuartero-Mart\u00ednez A, Touri\u00f1o-Peralba R, Rodr\u00edguez-Ares MT, Gir\u00e1ldez MJ, Yebra-Pimentel E et al. Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study. Int J Mol Sci [Internet]. Multidisciplinary Digital Publishing Institute; 2024 [cited 2026 June 22];25. https:\/\/doi.org\/10.3390\/ijms25189847","DOI":"10.3390\/ijms25189847"},{"key":"2189_CR23","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/molecules23051161","volume":"23","author":"P Saokham","year":"2018","unstructured":"Saokham P, Muankaew C, Jansook P, Loftsson T. Solubility of Cyclodextrins and Drug\/Cyclodextrin Complexes. Mol J Synth Chem Nat Prod Chem. 2018;23:1161. https:\/\/doi.org\/10.3390\/molecules23051161.","journal-title":"Mol J Synth Chem Nat Prod Chem"},{"key":"2189_CR24","unstructured":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes (Text with EEA relevance) [Internet]. June 26. 2019. http:\/\/data.europa.eu\/eli\/dir\/2010\/63\/2019-06-26. Accessed 26 June 2026."},{"key":"2189_CR25","doi-asserted-by":"publisher","unstructured":"OECD, Test. No. 437: Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage. OECD Guidel Test Chem Sect.\u00a0 4 [Internet]. OECD Publishing; 2025 [cited 2026 June 26]; https:\/\/doi.org\/10.1787\/9789264203846-en","DOI":"10.1787\/9789264203846-en"},{"key":"2189_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0278-6915(96)00100-7","volume":"35","author":"M Chamberlain","year":"1997","unstructured":"Chamberlain M, Gad SC, Gautheron P, Prinsen MK. Irag Working Group 1: Organotypic models for the assessment\/prediction of ocular irritation. Food Chem Toxicol. 1997;35:23\u201337. https:\/\/doi.org\/10.1016\/S0278-6915(96)00100-7.","journal-title":"Food Chem Toxicol"},{"key":"2189_CR27","unstructured":"ICCVAM. Recommended Test Method Protocol: Hen\u2019s Egg Test \u2013 Chorioallantoic Membrane (HET-CAM) Test Method. Obtained from [Internet]. 2010. https:\/\/ntp.niehs.nih.gov\/iccvam\/docs\/protocols\/ivocular-hetcam.pdf"},{"key":"2189_CR28","unstructured":"ARVO. The Association for Research in Vision and Ophthalmology- Statement for the Use of Animals in Ophthalmic and Vision Research [Internet]. 2021 [cited 2023 May 22]. https:\/\/www.arvo.org\/About\/policies\/statement-for-the-use-of-animals-in-ophthalmic-and-vision-research\/. Accessed 22 May 2023."},{"key":"2189_CR29","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1167\/iovs.16-20766","volume":"58","author":"A Fern\u00e1ndez-Ferreiro","year":"2017","unstructured":"Fern\u00e1ndez-Ferreiro A, Silva-Rodr\u00edguez J, Otero-Espinar FJ, Gonz\u00e1lez-Barcia M, Lamas MJ, Ruibal A, et al. Positron Emission Tomography for the Development and Characterization of Corneal Permanence of Ophthalmic Pharmaceutical Formulations. Invest Ophthalmol Vis Sci. 2017;58:772\u201380. https:\/\/doi.org\/10.1167\/iovs.16-20766.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2189_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/BF00137947","volume":"15","author":"JM Tiffany","year":"1991","unstructured":"Tiffany JM. The viscosity of human tears. Int Ophthalmol. 1991;15:371\u20136. https:\/\/doi.org\/10.1007\/BF00137947.","journal-title":"Int Ophthalmol"},{"key":"2189_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/OPX.0b013e3181824dc4","volume":"85","author":"H Zhu","year":"2008","unstructured":"Zhu H, Chauhan A. Effect of viscosity on tear drainage and ocular residence time. Optom Vis Sci Off Publ Am Acad Optom. 2008;85:715\u201325. https:\/\/doi.org\/10.1097\/OPX.0b013e3181824dc4.","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"key":"2189_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.clae.2017.09.005","volume":"41","author":"C Willshire","year":"2018","unstructured":"Willshire C, Buckley RJ, Bron AJ. Estimating basal tear osmolarity in normal and dry eye subjects. Contact Lens Anterior Eye J Br Contact Lens Assoc. 2018;41:34\u201346. https:\/\/doi.org\/10.1016\/j.clae.2017.09.005.","journal-title":"Contact Lens Anterior Eye J Br Contact Lens Assoc"},{"key":"2189_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4155\/bio.10.2","volume":"2","author":"SHS Boddu","year":"2010","unstructured":"Boddu SHS, Gunda S, Earla R, Mitra AK. Ocular microdialysis: a continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye. Bioanalysis. 2010;2:487\u2013507. https:\/\/doi.org\/10.4155\/bio.10.2.","journal-title":"Bioanalysis"},{"key":"2189_CR34","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s13346-016-0336-5","volume":"6","author":"I Bravo-Osuna","year":"2016","unstructured":"Bravo-Osuna I, Andr\u00e9s-Guerrero V, Pastoriza Abal P, Molina-Mart\u00ednez IT, Herrero-Vanrell R. Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases. Drug Deliv Transl Res. 2016;6:686\u2013707. https:\/\/doi.org\/10.1007\/s13346-016-0336-5.","journal-title":"Drug Deliv Transl Res"},{"key":"2189_CR35","first-page":"373","volume":"18","author":"R Gonnering","year":"1979","unstructured":"Gonnering R, Edelhauser HF, Van Horn DL, Durant W. The pH tolerance of rabbit and human corneal endothelium. Invest Ophthalmol Vis Sci. 1979;18:373\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2189_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1034\/j.1600-0420.2002.800102.x","volume":"80","author":"R Kuckelkorn","year":"2002","unstructured":"Kuckelkorn R, Schrage N, Keller G, Redbrake C. Emergency treatment of chemical and thermal eye burns. Acta Ophthalmol Scand. 2002;80:4\u201310. https:\/\/doi.org\/10.1034\/j.1600-0420.2002.800102.x.","journal-title":"Acta Ophthalmol Scand"},{"key":"2189_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejpb.2021.02.012","volume":"162","author":"A Conde Penedo","year":"2021","unstructured":"Conde Penedo A, D\u00edaz Tom\u00e9 V, Fern\u00e1ndez Ferreiro A, Gonz\u00e1lez Barcia M, Otero Espinar FJ. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking. Eur J Pharm Biopharm. 2021;162:12\u201322. https:\/\/doi.org\/10.1016\/j.ejpb.2021.02.012.","journal-title":"Eur J Pharm Biopharm"},{"key":"2189_CR38","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1021\/mp3005963","volume":"10","author":"PWJ Morrison","year":"2013","unstructured":"Morrison PWJ, Connon CJ, Khutoryanskiy VV. Cyclodextrin-Mediated Enhancement of Riboflavin Solubility and Corneal Permeability. Mol Pharm Am Chem Soc. 2013;10:756\u201362. https:\/\/doi.org\/10.1021\/mp3005963.","journal-title":"Mol Pharm Am Chem Soc"},{"key":"2189_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/pharmaceutics11070321","volume":"11","author":"RV Moiseev","year":"2019","unstructured":"Moiseev RV, Morrison PWJ, Steele F, Khutoryanskiy VV. Penetration Enhancers in Ocular Drug Delivery. Pharmaceutics. Multidisciplinary Digit Publishing Inst. 2019;11:321. https:\/\/doi.org\/10.3390\/pharmaceutics11070321.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"2189_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.chemolab.2005.05.010","volume":"82","author":"W Cai","year":"2006","unstructured":"Cai W, Yu Y, Shao X. Studies on the interaction of \u03b1-cyclodextrin with phospholipid by a flexible docking algorithm. Chemom Intell Lab Syst. 2006;82:260\u20138. https:\/\/doi.org\/10.1016\/j.chemolab.2005.05.010.","journal-title":"Chemom Intell Lab Syst"},{"key":"2189_CR41","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.3762\/bjoc.10.300","volume":"10","author":"T Furune","year":"2014","unstructured":"Furune T, Ikuta N, Ishida Y, Okamoto H, Nakata D, Terao K, et al. A study on the inhibitory mechanism for cholesterol absorption by \u03b1-cyclodextrin administration. Beilstein J Org Chem. 2014;10:2827\u201335. https:\/\/doi.org\/10.3762\/bjoc.10.300.","journal-title":"Beilstein J Org Chem"},{"key":"2189_CR42","doi-asserted-by":"publisher","first-page":"11112","DOI":"10.1021\/acs.jpcb.1c03916","volume":"125","author":"S Pandey","year":"2021","unstructured":"Pandey S, Xiang Y, Walpita Kankanamalage DVD, Jayawickramarajah J, Leng Y, Mao H. Measurement of Single-Molecule Forces in Cholesterol and Cyclodextrin Host-Guest Complexes. J Phys Chem B. 2021;125:11112\u201321. https:\/\/doi.org\/10.1021\/acs.jpcb.1c03916.","journal-title":"J Phys Chem B"},{"key":"2189_CR43","doi-asserted-by":"publisher","unstructured":"Horan IA, Loftsson T, Sigurdsson HH. The Chemical Stability Characterization and Kinetics of Statins in Aqueous Cyclodextrin Ocular Preparations: A Formulation Perspective. Pharmaceutics [Internet]. Multidisciplinary Digital Publishing Institute; 2025. [cited 2026 June 17];17. https:\/\/doi.org\/10.3390\/pharmaceutics17070808.","DOI":"10.3390\/pharmaceutics17070808"},{"key":"2189_CR44","doi-asserted-by":"publisher","first-page":"e0198831","DOI":"10.1371\/journal.pone.0198831","volume":"13","author":"SP Srinivas","year":"2018","unstructured":"Srinivas SP, Goyal A, Talele DP, Mahadik S, Sudhir RR, Murthy PP, et al. Corneal epithelial permeability to fluorescein in humans by a multi-drop method. PLoS ONE. 2018;13:e0198831. https:\/\/doi.org\/10.1371\/journal.pone.0198831.","journal-title":"PLoS ONE"},{"key":"2189_CR45","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1021\/mp500332m","volume":"11","author":"EA Mun","year":"2014","unstructured":"Mun EA, Morrison PWJ, Williams AC, Khutoryanskiy VV. On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein. Mol Pharm. 2014;11:3556\u201364. https:\/\/doi.org\/10.1021\/mp500332m.","journal-title":"Mol Pharm"},{"key":"2189_CR46","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1208\/s12249-015-0315-z","volume":"16","author":"GR Adelli","year":"2015","unstructured":"Adelli GR, Balguri SP, Majumdar S. Effect of Cyclodextrins on Morphology and Barrier Characteristics of Isolated Rabbit Corneas. AAPS PharmSciTech. 2015;16:1220\u20136. https:\/\/doi.org\/10.1208\/s12249-015-0315-z.","journal-title":"AAPS PharmSciTech"},{"key":"2189_CR47","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/stem.2667","volume":"35","author":"M Saghizadeh","year":"2017","unstructured":"Saghizadeh M, Kramerov AA, Svendsen CN, Ljubimov AV. Concise Review: Stem Cells for Corneal Wound Healing. Stem Cells Dayt Ohio. 2017;35:2105\u201314. https:\/\/doi.org\/10.1002\/stem.2667.","journal-title":"Stem Cells Dayt Ohio"},{"key":"2189_CR48","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1039\/C8SM01013G","volume":"14","author":"M Kluzek","year":"2018","unstructured":"Kluzek M, Schmutz M, Marques CM, Thalmann F. Kinetic evolution of DOPC lipid bilayers exposed to \u03b1-cyclodextrins. Soft Matter Royal Soc Chem. 2018;14:5800\u201310. https:\/\/doi.org\/10.1039\/C8SM01013G.","journal-title":"Soft Matter Royal Soc Chem"},{"key":"2189_CR49","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.3762\/bjoc.12.261","volume":"12","author":"L Leclercq","year":"2016","unstructured":"Leclercq L. Interactions between cyclodextrins and cellular components: Towards greener medical applications? Beilstein J Org Chem. 2016;12:2644\u201362. https:\/\/doi.org\/10.3762\/bjoc.12.261.","journal-title":"Beilstein J Org Chem"},{"key":"2189_CR50","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.2042-7158.2011.01279.x","volume":"63","author":"T Loftsson","year":"2011","unstructured":"Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes. J Pharm Pharmacol. 2011;63:1119\u201335. https:\/\/doi.org\/10.1111\/j.2042-7158.2011.01279.x.","journal-title":"J Pharm Pharmacol"},{"key":"2189_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","volume":"329","author":"T Loftsson","year":"2007","unstructured":"Loftsson T, Duch\u00eane D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329:1\u201311. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.10.044.","journal-title":"Int J Pharm"},{"key":"2189_CR52","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/pharmaceutics14040799","volume":"14","author":"R Varela-Fern\u00e1ndez","year":"2022","unstructured":"Varela-Fern\u00e1ndez R, Garc\u00eda-Otero X, D\u00edaz-Tom\u00e9 V, Regueiro U, L\u00f3pez-L\u00f3pez M, Gonz\u00e1lez-Barcia M, et al. Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery. Pharm Multidisciplinary Digit Publishing Inst. 2022;14:799. https:\/\/doi.org\/10.3390\/pharmaceutics14040799.","journal-title":"Pharm Multidisciplinary Digit Publishing Inst"},{"key":"2189_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejpb.2022.02.010","volume":"172","author":"R Varela-Fern\u00e1ndez","year":"2022","unstructured":"Varela-Fern\u00e1ndez R, Garc\u00eda-Otero X, D\u00edaz-Tom\u00e9 V, Regueiro U, L\u00f3pez-L\u00f3pez M, Gonz\u00e1lez-Barcia M, et al. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery. Eur J Pharm Biopharm. 2022;172:144\u201356. https:\/\/doi.org\/10.1016\/j.ejpb.2022.02.010.","journal-title":"Eur J Pharm Biopharm"},{"key":"2189_CR54","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/ACI.0b013e32830e6b04","volume":"8","author":"F Mantelli","year":"2008","unstructured":"Mantelli F, Arg\u00fceso P. Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol. 2008;8:477\u201383. https:\/\/doi.org\/10.1097\/ACI.0b013e32830e6b04.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2189_CR55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/bcpt.12342","volume":"116","author":"M Boegh","year":"2015","unstructured":"Boegh M, Nielsen HM. Mucus as a Barrier to Drug Delivery \u2013 Understanding and Mimicking the Barrier Properties. Basic Clin Pharmacol Toxicol. 2015;116:179\u201386. https:\/\/doi.org\/10.1111\/bcpt.12342.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2189_CR56","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10719-008-9136-6","volume":"25","author":"L Royle","year":"2008","unstructured":"Royle L, Matthews E, Corfield A, Berry M, Rudd PM, Dwek RA, et al. Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. Glycoconj J. 2008;25:763\u201373. https:\/\/doi.org\/10.1007\/s10719-008-9136-6.","journal-title":"Glycoconj J"},{"key":"2189_CR57","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1167\/iovs.11-8502","volume":"53","author":"PB Henrich","year":"2012","unstructured":"Henrich PB, Monnier CA, Halfter W, Haritoglou C, Strauss RW, Lim RYH, et al. Nanoscale topographic and biomechanical studies of the human internal limiting membrane. Invest Ophthalmol Vis Sci. 2012;53:2561\u201370. https:\/\/doi.org\/10.1167\/iovs.11-8502.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2189_CR58","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.molstruc.2018.08.094","volume":"1176","author":"A Zoppi","year":"2019","unstructured":"Zoppi A, Buhlman N, Cerutti JP, Longhi MR, Aiassa V. Influence of proline and \u03b2-Cyclodextrin in ketoconazole physicochemical and microbiological performance. J Mol Struct. 2019;1176:470\u20137. https:\/\/doi.org\/10.1016\/j.molstruc.2018.08.094.","journal-title":"J Mol Struct"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02189-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02189-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02189-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:15:59Z","timestamp":1785521759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02189-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":58,"alternative-id":["2189"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02189-4","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiments received approval from the Committee for Ethical Research of the Health Research Institute of Santiago de Compostela (IDIS) (2021\/430700) and were conducted in compliance with Spanish and European Union regulations (86\/609\/ CEE, 2003\/65\/CE, 2010\/63\/EU, RD 1201\/2005, and RD 53\/2013).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. The authors are only responsible for the content and writing of this article.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}